Methods and systems for determining ADAMTS13 enzyme activity Grant US-11959124-B2 United States of America 16 Apr 2024
Anti-C5 antibodies having improved pharmacokinetics Grant US-11434280-B2 United States of America 06 Sep 2022
High concentration anti-C5 antibody formulations Grant US-11365241-B2 United States of America 21 Jun 2022
COMPOSITIONS AND METHODS FOR TREATMENT OF HSCT-ASSOCIATED THROMBOTIC MICROANGIOPATHY Application EP-3750914-A1 European Patent Office 16 Dec 2020
Methods and systems for determining ADAMTS13 enzyme activity Grant US-10858689-B2 United States of America 08 Dec 2020
Methods of treatment of HSCT-associated thrombotic microangiopathy with eculizumab Grant US-10815296-B2 United States of America 27 Oct 2020
Methods of treating atypical hemolytic uremic syndrome and paroxysmal nocturnal… Grant US-10584164-B2 United States of America 10 Mar 2020
Methods of treating atypical hemolytic uremic syndrome with anti-C5 antibodies Grant US-10227400-B2 United States of America 12 Mar 2019
Anti-C5 antibodies having improved pharmacokinetics Grant US-9803007-B1 United States of America 31 Oct 2017
Heat-inactivated complement factor B compositions and methods Grant US-9534212-B2 United States of America 03 Jan 2017
COMPOSITIONS AND METHODS FOR TREATMENT OF HSCT-ASSOCIATED THROMBOTIC MICROANGIOPATHY Application WO-2015039126-A1 World Intellectual Property Organisation (WIPO) 19 Mar 2015